FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039498042> ?p ?o ?g. }

• W2039498042 endingPage "895" @default.
• W2039498042 startingPage "888" @default.
• W2039498042 abstract "The organophosphorus (OP) pesticide malathion is a highly neurotoxic compound and its toxicity is primarily caused by the inhibition of acetylcholinesterase (AChE), leading to cholinergic syndrome. Although oximes have been used as potential antidotal treatments in malathion poisoning because of their potential capability to reactivate the inhibited enzyme, the clinical experience with the clinically available oximes (e.g. pralidoxime) is disappointing and their routine use has been questioned. In the present study, we investigated the potency of pralidoxime and K074 in reactivating AChE after acute exposure to malathion, as well as in preventing malathion-induced changes in oxidative-stress related parameters in mice. Malathion (1.25 g/kg, s.c.) induced a significant decrease in cortico-cerebral, hippocampal and blood AChE activities at 24 h after exposure. Oxime treatments (1/4 of LD50, i.m., 6 h after malathion poisoning) showed that pralidoxime significantly reversed malathion-induced blood AChE inhibition, although no significant effects were observed after K074 treatment. Interestingly, both oximes tested were unable to reactivate the cortico-cerebral and hippocampal enzymes after intramuscular or intracerebroventricular injection (1/4 of LD50, 6 h after malathion poisoning). Biochemical parameters related to oxidative stress (cerebro-cortical and hippocampal glutathione peroxidase, glutathione reductase and catalase activities, as well as lipid peroxidation) were not affected in animals treated with malathion, oximes or atropine alone. However, pralidoxime and K074, administered intramuscularly 6 h after malathion poisoning, were able to increase the endogenous activities of these antioxidant enzymes in the prefrontal cortex and hippocampus. Taken together, the results presented herein showed that pralidoxime (the most common clinically used oxime) and the recently developed oxime K074, administered 6 h after malathion poisoning, were unable to reactivate the inhibited AChE in mouse prefrontal cortex and hippocampus. However, only pralidoxime significantly reversed the blood AChE inhibition induced by malathion poisoning. This indicates that peripheral and central AChE activities are not necessarily correlated after the treatment of OP compounds and/or oximes, which should be taken into account in the diagnosis and management of OP-exposed humans. In addition, considering that the available treatments to malathion poisoning appear to be ineffective, the present study reinforce the need to search for potential new AChE reactivators able to efficiently reactivate the brain and blood AChEs after malathion poisoning." @default.
• W2039498042 created "2016-06-24" @default.
• W2039498042 creator A5008473900 @default.
• W2039498042 creator A5016797870 @default.
• W2039498042 creator A5043468365 @default.
• W2039498042 creator A5051428255 @default.
• W2039498042 creator A5052692880 @default.
• W2039498042 creator A5062711165 @default.
• W2039498042 creator A5066903927 @default.
• W2039498042 creator A5068024387 @default.
• W2039498042 creator A5081516789 @default.
• W2039498042 creator A5083767621 @default.
• W2039498042 creator A5083982406 @default.
• W2039498042 date "2011-12-01" @default.
• W2039498042 modified "2023-10-18" @default.
• W2039498042 title "Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice" @default.
• W2039498042 cites W1122013619 @default.
• W2039498042 cites W1534119571 @default.
• W2039498042 cites W1589964883 @default.
• W2039498042 cites W1707439038 @default.
• W2039498042 cites W1965224657 @default.
• W2039498042 cites W1966312940 @default.
• W2039498042 cites W1969374006 @default.
• W2039498042 cites W1971048984 @default.
• W2039498042 cites W1979237945 @default.
• W2039498042 cites W1979424646 @default.
• W2039498042 cites W1984176315 @default.
• W2039498042 cites W1990735551 @default.
• W2039498042 cites W1993211322 @default.
• W2039498042 cites W2002128893 @default.
• W2039498042 cites W2007738922 @default.
• W2039498042 cites W2011091161 @default.
• W2039498042 cites W2011293737 @default.
• W2039498042 cites W2018512342 @default.
• W2039498042 cites W2021459784 @default.
• W2039498042 cites W2021811624 @default.
• W2039498042 cites W2025540286 @default.
• W2039498042 cites W2025773423 @default.
• W2039498042 cites W2028801421 @default.
• W2039498042 cites W2031151598 @default.
• W2039498042 cites W2036647579 @default.
• W2039498042 cites W2038600241 @default.
• W2039498042 cites W2042880806 @default.
• W2039498042 cites W2050756901 @default.
• W2039498042 cites W2051221701 @default.
• W2039498042 cites W2061502689 @default.
• W2039498042 cites W2065957780 @default.
• W2039498042 cites W2065959195 @default.
• W2039498042 cites W2067264952 @default.
• W2039498042 cites W2069171960 @default.
• W2039498042 cites W2079874336 @default.
• W2039498042 cites W2086306028 @default.
• W2039498042 cites W2089569398 @default.
• W2039498042 cites W2090719082 @default.
• W2039498042 cites W2090874210 @default.
• W2039498042 cites W2091989913 @default.
• W2039498042 cites W2095384268 @default.
• W2039498042 cites W2103509572 @default.
• W2039498042 cites W2108843737 @default.
• W2039498042 cites W2112872187 @default.
• W2039498042 cites W2114102865 @default.
• W2039498042 cites W2114811679 @default.
• W2039498042 cites W2126725371 @default.
• W2039498042 cites W2162344399 @default.
• W2039498042 cites W2170550342 @default.
• W2039498042 cites W2197332903 @default.
• W2039498042 cites W4293247451 @default.
• W2039498042 cites W2158736844 @default.
• W2039498042 doi "https://doi.org/10.1016/j.neuro.2011.05.008" @default.
• W2039498042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21723318" @default.
• W2039498042 hasPublicationYear "2011" @default.
• W2039498042 type Work @default.
• W2039498042 sameAs 2039498042 @default.
• W2039498042 citedByCount "20" @default.
• W2039498042 countsByYear W20394980422012 @default.
• W2039498042 countsByYear W20394980422013 @default.
• W2039498042 countsByYear W20394980422015 @default.
• W2039498042 countsByYear W20394980422016 @default.
• W2039498042 countsByYear W20394980422017 @default.
• W2039498042 countsByYear W20394980422018 @default.
• W2039498042 countsByYear W20394980422019 @default.
• W2039498042 countsByYear W20394980422020 @default.
• W2039498042 countsByYear W20394980422021 @default.
• W2039498042 countsByYear W20394980422022 @default.
• W2039498042 crossrefType "journal-article" @default.
• W2039498042 hasAuthorship W2039498042A5008473900 @default.
• W2039498042 hasAuthorship W2039498042A5016797870 @default.
• W2039498042 hasAuthorship W2039498042A5043468365 @default.
• W2039498042 hasAuthorship W2039498042A5051428255 @default.
• W2039498042 hasAuthorship W2039498042A5052692880 @default.
• W2039498042 hasAuthorship W2039498042A5062711165 @default.
• W2039498042 hasAuthorship W2039498042A5066903927 @default.
• W2039498042 hasAuthorship W2039498042A5068024387 @default.
• W2039498042 hasAuthorship W2039498042A5081516789 @default.
• W2039498042 hasAuthorship W2039498042A5083767621 @default.
• W2039498042 hasAuthorship W2039498042A5083982406 @default.
• W2039498042 hasBestOaLocation W20394980421 @default.
• W2039498042 hasConcept C161176658 @default.

• next